GenapSys Overview

  • Founded
  • 2010
Founded
  • Status
  • Private
  • Employees
  • 100
Employees
  • Latest Deal Type
  • Series D
  • Latest Deal Amount
  • $70M
Latest Deal Amount
  • Investors
  • 12

GenapSys General Information

Description

Developer of an electronic sequencing technology designed to gather data related to genomics. The company's technology leverages a proprietary electrical microfluidic sequencing chip with a scalable number of detectors and helping for applications ranging from targeted sequencing of specific amplicons to genome-scale sequencing data collection, enabling researchers or clinicians to deliver cost-effective and precise genetic testing.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Healthcare Technology Systems
Primary Office
  • 200 Cardinal Way
  • 3rd Floor
  • Redwood City, CA 94063
  • United States
+1 (800) 000-0000

GenapSys Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GenapSys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series D) 27-May-2021 $70M 00000 Completed Generating Revenue
9. Debt - PPP 10-Apr-2020 00.000 00000 Completed Generating Revenue
8. Debt - General 06-Feb-2020 0000 00000 Completed Generating Revenue
7. Later Stage VC (Series C) 20-Nov-2019 0000 00000 00000 Completed Generating Revenue
6. Later Stage VC (Series C) 02-Jan-2018 000.00 000.00 Completed Generating Revenue
5. Grant 01-Jan-2015 00.000 0000 Completed Startup
4. Early Stage VC (Series B) 21-Nov-2013 000.00 0000 00000 Completed Startup
3. Early Stage VC (Series A) 21-Mar-2013 00.000 00.000 000.00 Completed Startup
2. Grant 01-Sep-2012 $4M Completed Startup
1. Accelerator/Incubator Completed Startup
To view GenapSys’s complete valuation and funding history, request access »

GenapSys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Series C 0,000,000 00.000000 000.00 000.00 00 000.00 0.000
Series B 6,127,325 $0.001000 $5.95 $5.95 1x $5.95 12.21%
Series A 8,493,002 $0.001000 $1 $1 1x $1 16.92%
To view GenapSys’s complete cap table history, request access »

GenapSys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an electronic sequencing technology designed to gather data related to genomics. The company's technology l
Diagnostic Equipment
Redwood City, CA
100 As of 2021
00000
00000000000 00000

000 0000

nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit
0000000000 000000000
London, United Kingdom
000 As of 0000
000.00
00.00 0000-00-00
0000000000 0 000.00

0000000

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et
0000000000000
San Diego, CA
000 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GenapSys Competitors (19)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DNA Electronics Venture Capital-Backed London, United Kingdom 000 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
0000000 0000000000 Formerly VC-backed Menlo Park, CA 000 00000 000000&0
000000000 Formerly VC-backed Fremont, CA 000 000.00 000000&0 000.00
000000000 Formerly VC-backed San Francisco, CA 000000&0
You’re viewing 5 of 19 competitors. Get the full list »

GenapSys Executive Team (18)

Name Title Board Seat Contact Info
Britton Russell Chief Financial Officer
Mary Stewart Chief Operating Officer
Xavier Gomes Ph.D Director of Sequencing
Ashok Ramachandran Director, Product & Test Engineering
Hesaam Esfandyarpour Ph.D Founder & Chairman
You’re viewing 5 of 18 executive team members. Get the full list »

GenapSys Board Members (25)

Name Representing Role Since
Ali Mani Ph.D Self Board Member & Advisor 000 0000
Andreas Marx Self Board Member & Advisor 000 0000
David Tse Ph.D Self Board Member & Advisor 000 0000
Diana McKenzie Self Board Member 000 0000
Eric Topol MD Self Board Member & Advisor 000 0000
You’re viewing 5 of 25 board members. Get the full list »

GenapSys Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GenapSys Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Farallon Capital Management Hedge Fund Minority 000 0000 000000 0
PBM Capital Group PE/Buyout Minority 000 0000 000000 0
Soleus Capital PE/Buyout Minority 000 0000 000000 0
Foresite Capital Management Growth/Expansion Minority 000 0000 000000 0
Small Business Innovation Research and Small Business Technology Transfer Programs Government Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »